Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Circle Pharma, a spinout of UCSF and UC Santa Cruz, has collected series B funding from investors including another UC campus, Berkeley.

Eli Lilly took part in an $80.3m round that pushed chronic illness drug developer Sigilon Therapeutics' overall funding to nearly $200m.

Existing backer ShangPharma reinvested in a series B round for the Pfizer-backed macrocyclic peptide drug developer.

Meituan Dianping's budget hotel spinoff has secured an eight-figure dollar sum, in a round co-led by Sofina Group and GGV Capital.

Google unit Gradient Ventures and Square have taken part in a $28m round for Oura, the developer of a wearable sleep tracker.

Huya, NTT Docomo Ventures and Samsung Ventures have provided a $6m extension for the livestreaming monetisation platform's latest round.

Edge computing network provider has pushed its total funding to $396m in a series B round co-led by Juniper Networks and Cox Communications.

WeWork-backed Proxy has raised series B funding that will help it expand its online-to-offline identity verification system across multiple continents.

Microsoft, PayU, Boston Consulting Group, CMT Digital and founding investor Intercontinental Exchange all backed the digital wallet provider's series B round.